CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | -58.3% | 26,335 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 26,335 | 0.0% | 0.00% | – |
| Q2 2018 | $13,000 | -78.7% | 26,335 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $61,000 | -18.7% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $75,000 | 0.0% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $75,000 | +15.4% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $65,000 | -31.6% | 26,335 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $95,000 | +2.2% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | -12.3% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $106,000 | -7.8% | 26,335 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $115,000 | +16.2% | 26,335 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $99,000 | -76.0% | 26,335 | 0.0% | 0.00% | -77.8% |
| Q4 2015 | $413,000 | +49.1% | 26,335 | 0.0% | 0.01% | +80.0% |
| Q3 2015 | $277,000 | -58.3% | 26,335 | 0.0% | 0.01% | -50.0% |
| Q2 2015 | $664,000 | -9.5% | 26,335 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $734,000 | +52.6% | 26,335 | 0.0% | 0.01% | +66.7% |
| Q4 2014 | $481,000 | +41.1% | 26,335 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $341,000 | -20.7% | 26,335 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $430,000 | -7.5% | 26,335 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $465,000 | -27.1% | 26,335 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $638,000 | -31.6% | 26,335 | 0.0% | 0.01% | -38.5% |
| Q3 2013 | $933,000 | +127.6% | 26,335 | +0.2% | 0.01% | +116.7% |
| Q2 2013 | $410,000 | – | 26,294 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |